These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31682648)

  • 1. Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Tan B; Ismail S;
    Can Commun Dis Rep; 2010 Sep; 36(ACS-8):1-26. PubMed ID: 31682648
    [No Abstract]   [Full Text] [Related]  

  • 2. Literature Review on One-Dose and Two-Dose Varicella Vaccination: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Campbell A; Ismail S; Tan B;
    Can Commun Dis Rep; 2010 Oct; 36(ACS-10):1-24. PubMed ID: 31682662
    [No Abstract]   [Full Text] [Related]  

  • 3. Updated Recommendations for the Use of Varicella and MMR Vaccines In HIV-Infected Individuals: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Tan B; Ismail S;
    Can Commun Dis Rep; 2010 Sep; 36(ACS-7):1-19. PubMed ID: 31682653
    [No Abstract]   [Full Text] [Related]  

  • 4. Statement on Measles-Mumps-Rubella-Varicella Vaccine: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Tan B; Ismail S;
    Can Commun Dis Rep; 2010 Sep; 36(ACS-9):1-22. PubMed ID: 31682661
    [No Abstract]   [Full Text] [Related]  

  • 5. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2002 Feb; 28(ACS-3):1-7. PubMed ID: 11875774
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommendations on the use of live, attenuated influenza vaccine (FluMist
    This statement was prepared and approved by NACI.
    Can Commun Dis Rep; 2011 Nov; 37(ACS-7):1-77. PubMed ID: 31682654
    [No Abstract]   [Full Text] [Related]  

  • 7. Recommendations on the use of MF59-Adjuvanted Trivalent Influenza Vaccine (Fluad
    This statement was prepared by CADTH and approved by NACI.
    Can Commun Dis Rep; 2011 Oct; 37(ACS-6):1-68. PubMed ID: 31701945
    [No Abstract]   [Full Text] [Related]  

  • 8. Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2011 Oct; 37(ACS-5):1-55. PubMed ID: 31682646
    [No Abstract]   [Full Text] [Related]  

  • 9. Updated Statement on the use of Rotavirus Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2010 Jul; 36(ACS-4):1-37. PubMed ID: 31701956
    [No Abstract]   [Full Text] [Related]  

  • 10. STATEMENT ON THE RECOMMENDED USE OF HERPES ZOSTER VACCINE: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)*
    Laupland K;
    Can Commun Dis Rep; 2010 Jan; 36(ACS-1):1-19. PubMed ID: 31682655
    [No Abstract]   [Full Text] [Related]  

  • 11. Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    This statement was prepared and approved by NACI.
    Can Commun Dis Rep; 2010 Aug; 36(ACS-6):1-49. PubMed ID: 31682656
    [No Abstract]   [Full Text] [Related]  

  • 12. Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Desai S; McGeer A; Quach-Thanh C; Elliott D;
    Can Commun Dis Rep; 2010 Nov; 36(ACS-12):1-21. PubMed ID: 31697280
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Dawar DM; Harris MT; McNeil DS;
    Can Commun Dis Rep; 2012 Jan; 38(ACS-1):1-62. PubMed ID: 31701955
    [No Abstract]   [Full Text] [Related]  

  • 14. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023-2024.
    Sinilaite A; Siu W; Papenburg J
    Can Commun Dis Rep; 2023 Oct; 49(10):406-412. PubMed ID: 38476927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)
    Ford-Jones EL; Calvin S;
    Can Commun Dis Rep; 2010 Nov; 36(ACS-14):1-31. PubMed ID: 31701942
    [No Abstract]   [Full Text] [Related]  

  • 16. Summary of the National Advisory Committee on Immunization (NACI) Statement on Seasonal Influenza Vaccine for 2016-2017.
    Gemmill I; Zhao L; Cochrane L;
    Can Commun Dis Rep; 2016 Sep; 42(9):188-192. PubMed ID: 29770030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season.
    Tam T; Langley J;
    Can Commun Dis Rep; 2004 Mar; 30():1-5. PubMed ID: 15035403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2022-2023.
    Sinilaite A; Papenburg J
    Can Commun Dis Rep; 2022 Sep; 48(9):373-382. PubMed ID: 38116046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2021-2022.
    Can Commun Dis Rep; 2021 Sep; 47(9):372-380. PubMed ID: 34650334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1998-1999 season.
    Can Commun Dis Rep; 1998 Jul; 24():1-12. PubMed ID: 10330776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.